Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

NCT04354064 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04354064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04354064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Recruiting
Start date
May 29, 2019
Completion date
December 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colon cancer, esophageal cancer, gastrointestinal cancer, genitourinary cancer, head and neck cancer, healthy volunteer, lung cancer, melanoma, prostate cancer, sarcoma, skin cancer, solid tumor cancer